Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination

European Journal of Immunology

Volumn 42, Issue 9, 2012, Pages 2511-2522

  Smith, Steven G ^a   Lecher, Sophie ^b,c   Blitz, Rose ^a   Locht, Camille ^b,c   Dockrell, Hazel M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INSERM U1019   (France)

^c UNIV LILLE   (France)

Author keywords

BCG vaccination; Chemokines; Cytokines; Heparin binding haemagglutinin (HBHA); Tuberculosis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HEMAGGLUTININ; HEPARIN BINDING HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BCG VACCINATION; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; INFANT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL;

ADOLESCENT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINES; COHORT STUDIES; HEPARIN; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKINS; MEMBRANE PROTEINS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865744202     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142297     Document Type: Article

References (35)

1. Wilson, M. E., Fineberg, H. V. and Colditz, G. A., Geographic latitude and the efficacy of bacillus Calmette-Guerin vaccine. Clin. Infect. Dis. 1995. 20: 982-991.
2. Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E. and Fineberg, H. V., The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995. 96: 29-35.
3. Trunz, B. B., Fine, P. and Dye, C., Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006. 367: 1173-1180.
4. Barreto, M. L., Cunha, S. S., Pereira, S. M., Genser, B., Hijjar, M. A., Yury Ichihara, M., de Brito, S. C. et al., Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. Int. J. Tuberc. Lung Dis. 2005. 9: 1171-1173.
5. Dantas, O. M., Ximenes, R. A., de Albuquerque Mde, F., da Silva, N. L., Montarroyos, U. R., de Souza, W. V., Pereira, T. C. et al., A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil. Int. J. Tuberc. Lung Dis. 2006. 10: 536-541.
6. McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A. et al., Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 2004. 10: 1240-1244.
7. Beveridge, N. E., Price, D. A., Casazza, J. P., Pathan, A. A., Sander, C. R., Asher, T. E., Ambrozak, D. R. et al., Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur. J. Immunol. 2007. 37: 3089-3100.
8. Menozzi, F. D., Rouse, J. H., Alavi, M., Laude-Sharp, M., Muller, J., Bischoff, R., Brennan, M. J. et al., Identification of a heparin-binding hemagglutinin present in mycobacteria. J. Exp. Med. 1996. 184: 993-1001.
9. Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C. and Menozzi, F. D., The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001. 412: 190-194.
10. Masungi, C., Temmerman, S., Van Vooren, J. P., Drowart, A., Pethe, K., Menozzi, F. D., Locht, C. et al., Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 2002. 185: 513-520.
11. Temmerman, S. T., Place, S., Debrie, A. S., Locht, C. and Mascart, F., Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis. J. Infect. Dis. 2005. 192: 226-232.
12. van Pinxteren, L. A., Cassidy, J. P., Smedegaard, B. H., Agger, E. M. and Andersen, P., Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 2000. 30: 3689-3698.
13. Temmerman, S., Pethe, K., Parra, M., Alonso, S., Rouanet, C., Pickett, T., Drowart, A. et al., Methylation-dependent Tcell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat. Med. 2004. 10: 935-941.
14. Rahman, M. J. and Fernandez, C., Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol. Vaccine 2009. 27: 4038-4046.
15. Rouanet, C., Debrie, A. S., Lecher, S. and Locht, C., Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis. Microbes. Infect. 2009. 11: 995-1001.
16. Guerrero, G. G. and Locht, C., Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection. Clin. Dev. Immunol. 2011. 2011: 730702.
17. Lalor, M. K., Smith, S. G., Floyd, S., Gorak-Stolinska, P., Weir, R. E., Blitz, R., Branson, K. et al., Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 2010. 28: 1635-1641.
18. Burl, S., Adetifa, U. J., Cox, M., Touray, E., Ota, M. O., Marchant, A., Whittle, H. et al., Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J. Immunol. 2010. 185: 2620-2628.
19. Kagina, B. M., Abel, B., Bowmaker, M., Scriba, T. J., Gelderbloem, S., Smit, E., Erasmus, M. et al., Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 2009. 27: 5488-5495.
20. Hougardy, J. M., Schepers, K., Place, S., Drowart, A., Lechevin, V., Verscheure, V., Debrie, A. S. et al., Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One 2007. 2: e926.
21. Smith, S. G., Lalor, M. K., Gorak-Stolinska, P., Blitz, R., Beveridge, N. E., Worth, A., McShane, H. et al., Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. BMC Immunol. 2010. 11: 35.
22. Soares, A. P., Scriba, T. J., Joseph, S., Harbacheuski, R., Murray, R. A., Gelderbloem, S. J., Hawkridge, A. et al., Bacillus calmette-guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 2008. 180: 3569-3577.
23. Tomlinson, G. S., Cashmore, T. J., Elkington, P. T., Yates, J., Lehloenya, R. J., Tsang, J., Brown, M. et al., Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test. Eur. J. Immunol. 2011. 41: 3253-3260.
24. Lalor, M. K., Ben-Smith, A., Gorak-Stolinska, P., Weir, R. E., Floyd, S., Blitz, R., Mvula, H. et al., Population differences in immune responses to bacille Calmette-Guerin vaccination in infancy. J. Infect. Dis. 2009. 199: 795-800.
25. Ottenhoff, T. H., De Boer, T., van Dissel, J. T. and Verreck, F. A., Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv. Exp. Med. Biol. 2003. 531: 279-294.
26. Pearl, J. E., Saunders, B., Ehlers, S., Orme, I. M. and Cooper, A. M., Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. Cell Immunol. 2001. 211: 43-50.
27. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A. and Bloom, B. R., An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993. 178: 2249-2254.
28. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G. and Orme, I. M., Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 1993. 178: 2243-2247.
29. Black, G. F., Weir, R. E., Floyd, S., Bliss, L., Warndorff, D. K., Crampin, A. C., Ngwira, B. et al., BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002. 359: 1393-1401.
30. Wedlock, D. N., Denis, M., Vordermeier, H. M., Hewinson, R. G. and Buddle, B. M., Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 2007. 118: 50-58.
31. Elias, D., Akuffo, H. and Britton, S., PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 2005. 99: 363-368.
32. Majlessi, L., Simsova, M., Jarvis, Z., Brodin, P., Rojas, M. J., Bauche, C., Nouze, C. et al., An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect. Immun. 2006. 74: 2128-2137.
33. Mittrucker, H. W., Steinhoff, U., Kohler, A., Krause, M., Lazar, D., Mex, P., Miekley, D. et al., Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc. Natl. Acad. Sci. USA 2007. 104: 12434-12439.
34. Anderson, L., Moore, J., Kruijshaar, M., Pedrazzoli, D., Bradshaw, L., Crofts, J., Stagg, H. et al., Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK, 2010. Health Protection Agency Centre for Infections, London, October 2010.
35. Anderson, C., Maguire, H., Anderson, S., Carless, J. and Kanfoudi, L., Tuberculosis in London 2009: annual report on tuberculosis surveillance in London. Health Protection Agency London Regional Epidemiology Unit, London, January 2011.